Evidence map›Paper›PMID 14760536›Full record

ReviewLangenbeck's archives of surgery2004

Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Martin H Holtmann, Peter R Galle

Abstract readReview
PubMed Publisher
In one paragraph

Review in Langenbeck's archives of surgery, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. State-of-the-art surgery for ulcerative colitis.Langenbeck's archives of surgery · 2021
    Article
  3. Observational
  4. Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment.World journal of gastrointestinal pharmacology and therapeutics · 2017
    Review
  5. Article
  6. Article
  7. Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2010
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Martin H HoltmannDepartment of Medicine, Johannes Gutenberg University, Langenbeckstrasse 1, 55131 Mainz, Germany. mholtman@mail.uni-mainz.de
Peter R Galle
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAccording to the current paradigm both ulcerative colitis (UC) and Crohn's disease (CD) result from a complex interplay of genetic susceptibility factors, environmental factors, alterations of the physiological intestinal flora and a defective regulation of the intestinal immune system. DISCUSSION: The objective of this review is to give an overview of these factors and mechanisms, including genetic, environmental and microbial factors, with special alterations of relevant cellular components of the intestinal immune system such as T cells, macrophages and epithelial cells will then be addressed. In addition, the most relevant animal model systems that have contributed to our current pathogenetic understanding will be introduced. Clinically, the natural course of UC with special reference to the risk of colorectal cancer will be addressed.

conclusionThe elucidation of pathomechanisms at the level of the intestinal immune system provides the potential for novel, effective treatment strategies. Best surgical management of patients with UC, however, still remains a challenge.

Indexed as

Colitis, UlcerativeAdolescentAdrenal Cortex HormonesAdultAnimalsAnti-Inflammatory Agents, Non-SteroidalColectomyControlled Clinical Trials as TopicDisease Models, AnimalGenetic Predisposition to DiseaseHumansImmunosuppressive AgentsMacrophagesMesalamineMiceMice, KnockoutAdrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalImmunosuppressive AgentsMesalamine

Identifiers

PMID14760536
OpenAlexW2045218075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.